Mangoceuticals, Inc. - Common Stock (MGRX)
2.1400
-0.0100 (-0.47%)
NASDAQ · Last Trade: Apr 2nd, 5:41 PM EDT
Detailed Quote
Previous Close | 2.150 |
---|---|
Open | 2.090 |
Bid | 2.020 |
Ask | 2.140 |
Day's Range | 2.025 - 2.270 |
52 Week Range | 1.800 - 16.80 |
Volume | 55,000 |
Market Cap | - |
PE Ratio (TTM) | - |
EPS (TTM) | - |
Dividend & Yield | N/A (N/A) |
1 Month Average Volume | 242,429 |
About Mangoceuticals, Inc. - Common Stock (MGRX)
Mangoceuticals, Inc. is a biotechnology company focused on developing innovative wellness and lifestyle products that leverage the benefits of natural ingredients. The company specializes in formulating and marketing supplements aimed at enhancing men's health, vitality, and overall quality of life. By combining cutting-edge research with the power of nature, Mangoceuticals aims to provide consumers with effective and safe solutions for improving their well-being, all while promoting a healthier lifestyle. Through its commitment to quality and sustainability, the company seeks to establish itself as a leader in the health and wellness industry. Read More
News & Press Releases
Here are the top movers in Tuesday's session, showcasing the stocks with significant price changes.
Via Chartmill · March 25, 2025
Keep an eye on the top gainers and losers in Tuesday's session, as they reflect the most notable price movements.
Via Chartmill · March 25, 2025
The market is buzzing with gapping stocks on Tuesday. Let's uncover which stocks are experiencing notable gaps during today's session.
Via Chartmill · March 25, 2025

Men's Telehealth Company's Plans To Change Men's Wellness
Via News Direct · September 26, 2024

Mangoceuticals just reported results for the second quarter of 2024.
Via InvestorPlace · August 15, 2024
Via Benzinga · March 21, 2025

Via Benzinga · October 17, 2024

Via Benzinga · October 11, 2024

Via Benzinga · October 10, 2024

Via Benzinga · October 8, 2024

Dallas, TX Based Men's Health Telemedicine Company Announces Successful Participation in Beijing Exhibit
Via ACCESSWIRE · August 8, 2024

Via Benzinga · October 4, 2024

Via Benzinga · October 4, 2024

Via Benzinga · October 3, 2024

Via Benzinga · October 1, 2024

Prescribing The Future: How MangoRx Is Shaking Up Telemedicine With A Fresh Platform
Via News Direct · September 5, 2024

This Men’s Telehealth Company Has A Unique Take On Telehealth And Products
Via News Direct · July 25, 2024

Emerging Telemedicine Leaders: Stocks Shaping Healthcare's Digital Future
Via News Direct · July 25, 2024

Erectile Function Vs Erectile Dysfunction: How MangoRx’s (NASDAQ: MGRX) Product Sets Itself Apart and Caters to a Large Market (Pun Intended)
Via News Direct · July 10, 2024

Via Benzinga · June 5, 2024

Pre-market stock movers are a hot topic as investors return to trading on Tuesday following the long holiday weekend!
Via InvestorPlace · May 28, 2024

DALLAS, TX / ACCESSWIRE / May 23, 2024 / Mangoceuticals, Inc. (NASDAQ:MGRX) ("MangoRx" or the "Company"), a company focused on developing, marketing, and selling a variety of men's health and wellness products in the area of erectile dysfunction (ED), hair growth, hormone replacement therapies and weight loss is excited to announce that it has engaged renown international performance marketing company, Crakmedia to champion the Company's ongoing creative and digital marketing initiatives.
Via ACCESSWIRE · May 23, 2024

Via Benzinga · May 22, 2024